Nova Financial’s Myriad Genetics MYGN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$108 Buy
+25
New +$105 ﹤0.01% 834

Other funds holding MYGN

Nova Financial's MYGN Position: Q3 2026 in Review

Nova Financial opened a new position in Myriad Genetics (MYGN) in Q3 2026: 25 shares worth $108. The stake represents ﹤0.01% of the portfolio and ranks #834 among its holdings.

175 funds tracked by Wall St. Rank hold MYGN as of Q3 2026.

  • Nova Financial held 25 shares of Myriad Genetics worth $108 as of Q3 2026.
  • Myriad Genetics was a new Nova Financial position in Q3 2026.
  • Myriad Genetics made up ﹤0.01% of Nova Financial's portfolio in Q3 2026, its #834 holding.
  • 175 funds tracked by Wall St. Rank held Myriad Genetics as of Q3 2026.

Based on Nova Financial's 13F filing for Q3 2026, filed 4 Nov 2026.